Upgrade to SI Premium - Free Trial

KaloBios Pharma (KBIO) CEO Shkreli Highlights 'Most Important Paper' on Company

November 24, 2015 9:41 AM
KaloBios Pharma (NASDAQ: KBIO) CEO Martin Shkreli highlighted what he called "the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA Management Comments Trader Talk

Next Articles